PG vs PMCB · P/E 25, rev $84.28B vs $8.6M cap
Procter & Gamble Company (PG) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the PG and PMCB stock pages for the full models.
Not investment advice.